Chemoimmunotherapy with O-FC previously untreated patients with chronic lymphocytic leukemia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F11%3A10106211" target="_blank" >RIV/00216208:11150/11:10106211 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/11:10106211
Result on the web
<a href="http://bloodjournal.hematologylibrary.org/content/117/24/6450.full" target="_blank" >http://bloodjournal.hematologylibrary.org/content/117/24/6450.full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1182/blood-2010-12-323980" target="_blank" >10.1182/blood-2010-12-323980</a>
Alternative languages
Result language
angličtina
Original language name
Chemoimmunotherapy with O-FC previously untreated patients with chronic lymphocytic leukemia
Original language description
We conducted an international phase 2 trial to evaluate 2 dose levels of ofatumumab, a human CD20 mAb, combined with fludarabine and cyclophosphamide (O-FC) as frontline therapy for chronic lymphocytic leukemia (CLL). O-FC is active and safe in treatment-naive patients with CLL, including high-risk patients.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Blood
ISSN
0006-4971
e-ISSN
—
Volume of the periodical
117
Issue of the periodical within the volume
24
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
6450-6458
UT code for WoS article
000291684300010
EID of the result in the Scopus database
—